Radar · Life Sciences Tech in Boston
Best Life Sciences Tech Companies in Boston, United States
The 107 best Life Sciences Tech companies in Boston, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Genuity Science.
By Rohit KhannaTrends & Stories
107companies tracked
$4Bdisclosed funding
2unicorns
52have raised
FLIAR INTELLIGENCE · LIFE SCIENCES TECH × BOSTON
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
50companies analysed
89%cloud-native stacks
2025funding peak (by rounds)
8unicorns
2018median founding year
425kcombined LinkedIn audience
48%of audience held by top 3
4companies hiring publicly (12 mo)
Ranked: Best Life Sciences Tech companies in Boston
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Genuity Science Provider of omics data analysis solutions for researchers | $515M | 90 mo ago | Acquired | 140 | Jeff Gulcher Co-Founder & CSO | WordPressMySQLPHP+18 | — | — |
| 2 | Reify Health 🦄 Mobile health platform for doctors to manage clinical trials | $478M | 50 mo ago | Series D | 71 | Michael Lin Executive Chairman & Co-Founder | — | — | — |
| 3 | Valo Health AI-powered platform for drug discovery and development | $450M | 63 mo ago | Series B | 117 117 → 214 (+83%) | Brian Alexander Chief Executive Officer | Craft CMSApple iCloud MailPHP+16 | 150 patents Organ-on-chip 3D tissue platforms and ubiquitin‑targeted small‑molecule therapeutics | 1 award |
| 4 | SmartLabs Developer of smart labs and lab spaces | $334M | 29 mo ago | Series C | 172 | Amrit Chaudhuri Co-Founder & CEO | WebflowBeaver BuilderWordPress+26 | 76 patents IoT-based communication and control systems for smart building automation and modular devices | 2 expansions |
| 5 | Concert AI 🦄 Provider of AI and real-world data solutions for life sciences | $300M | 50 mo ago | Series C | 1,000 | — | HubSpot CMS HubSentryApple iCloud Mail+29 | 139 patents Patents concentrated in electrical & electronics | — |
| 6 | PathAI Provider of digital pathology image management system for clinical labs | $255M | 61 mo ago | Series C | 573 | Andrew Beck Co-Founder & CEO | HubSpot CMS HubApple iCloud MailGoogle Workspace+18 | 45 patents AI-driven digital pathology analysis and tissue characterization using advanced machine learning models | 1 launch |
| 7 | Apprentice AI-based manufacturing processing and management tool for pharmaceutical industry | $247M | 39 mo ago | Series C | 152 | Angelo Stracquatanio III Co-Founder & CEO | WebflowTypeScriptAngular+11 | 53 patents Remote digital workflow automation and video guidance for legacy manufacturing equipment | — |
| 8 | HotSpot Therapeutics Developer of a platform for protein function analysis | $210M | 54 mo ago | Series C | 37 37 → 59 (+59%) | Jonathan Montagu President & Chief Executive Officer | WordPressMySQLPHP+17 | — | — |
| 9 | Asimov Provider of integrated suite for advanced genetic design and manufacturing | $209M | 41 mo ago | Series B | 64 64 → 119 (+86%) | Chris Voigt Co-Founder | WebflowMicrosoft AdvertisingSendgrid+18 | 70 patents Efficient manufacturing of recombinant viral vectors for gene therapy applications | 1 launch · 1 partnership |
| 10 | TetraScience Provider of a cloud-based data platform for life science industry 40Funding top 21%Growth top 26%Moat top 35%Tech top 50% All 9 signals ▾Fundingtop 21% Growthtop 26% Moattop 35% Techtop 50% Newsbottom 47% Globalbottom 39% Marketbottom 38% Patentsbottom 25% Innovationbottom 22% Funding: Raised $99.2M across 6 rounds · 6 rounds over 12 yrs (0.5/yr) Growth: Headcount 13 → 30 (+131%) across vintages · Web rank 5,000,000 → 10,000,000 YoY rank vs industry peers · Fliar Intelligence Index 40/100 | $99M | 4 mo ago | Series B | 30 | — | WebflowApple iCloud MailGoogle Workspace+21 | 4 patents Real-time monitoring and feedback control systems for industrial tools and equipment | 1 job opening |
| 11 | GRO Biosciences Developer of re-coding synthetic biology tools | $91M | 23 mo ago | Series B | 22 | Daniel Mandell CEO | — | — | — |
| 12 | AcuityMD Platform offering CRM software to the medical industry 53Funding top 18%News top 25%Talent top 28%Growth top 35% All 10 signals ▾Fundingtop 18% Newstop 25% Talenttop 28% Growthtop 35% Producttop 36% Moattop 39% Techtop 48% Marketbottom 42% Innovationbottom 37% Globalbottom 34% Funding: Raised $83.0M across 4 rounds · 4 rounds over 5 yrs (0.8/yr) News: 4 BI events in 12 mo (of 11 tracked, 3 types) · Top themes: Funding, New product rank vs industry peers · Fliar Intelligence Index 53/100 | $83M | 2 mo ago | Series C | 48 | Michael Monovoukas Co-Founder & CEO | WebflowApple iCloud MailGoogle Workspace+20 | — | — |
| 13 | Panalgo Provider of healthcare analytics software for clinics | $78M | 85 mo ago | Acquired | 111 | — | Apple iCloud MailZURB FoundationAmazon Web Services+12 | — | 2 launchs |
| 14 | DeepCure AI-driven drug discovery platform for inflammation & immunology space | $72M | 26 mo ago | Series A | 22 22 → 27 (+23%) | Kfir Schreiber Co-Founder & CEO | — | 10 patents AI-driven drug discovery and automated chemical synthesis workflow optimization | — |
| 15 | Ampersand Developer of programmable medicines to treat multiple diseases 42AI top 15%Funding top 24%Talent top 38%Moat top 40% All 10 signals ▾AItop 15% Fundingtop 24% Talenttop 38% Moattop 40% Growthtop 43% Patentsbottom 45% Techbottom 43% Globalbottom 38% Innovationbottom 30% Marketbottom 29% AI: Holds AI/ML patents (G06N-family CPC) Funding: Raised $65.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 42/100 | $65M | 15 mo ago | Series B | 22 | Raffi Afeyan Co-Founder & Chief Innovation Officer | WebflowTypekitGoogle Font API+12 | 5 patents Audio signal analysis and filtering, plus multidimensional GUI for database interaction | 1 partnership |
| 16 | DeepCure Developer of novel small molecule therapies for immune diseases | $65M | 26 mo ago | Series A | — | Thrasyvoulos Karydis Co-Founder & CTO | Cart FunctionalitySquarespace CommerceSquarespace+12 | 10 patents AI-driven drug discovery and automated chemical synthesis workflow optimization | — |
| 17 | Magnet Biomedicine Developer of a research platform for molecular glue medicines | $50M | 33 mo ago | Series A | 20 | Stuart Schreiber Co-Founder | SanityReactGSAP+10 | — | — |
| 18 | Invicro Provide contract research imaging services and software | $46M | 120 mo ago | Acquired | 308 | — | Apple iCloud MailBootstrapVideoJS+11 | 49 patents Advanced multi‑modal medical imaging: particle emission (PET) and fluorescence tomography systems | — |
| 19 | Reverie Labs Provider of an AI based molecular modelling and optimization software for research & development | $32M | 64 mo ago | Acquired | 27 | Jonah Kallenbach Co-Founder & CEO | — | 6 patents Patents concentrated in computing, sensing & instrumentation | — |
| 20 | Centaur Labs Provider of medical data labeling solutions for AI development | $31M | 20 mo ago | Series B | — | Zach Rausnitz Co-Founder & CTO | WebflowZohoAmazon Web Services+26 | 68 patents Microprocessor architecture and design, focusing on branch prediction, multi‑core, and clock generation | 2 job openings |
| 21 | Pi Health Provider of an AI-native platform for managing clinical trials end-to-end 62Patents top 20%Moat top 21%Growth top 28%Innovation top 31% All 11 signals ▾Patentstop 20% Moattop 21% Growthtop 28% Innovationtop 31% Fundingtop 31% Talenttop 38% AItop 45% Techbottom 47% Globalbottom 45% Marketbottom 29% Newsbottom 18% Patents: 9,865 patents matched (strict assignee match) · 2246 filings since 2022 vs 3287 in 2017-21 Moat: Editorial + unicorn rating 7/10 · IP moat: 9,865 patents rank vs industry peers · Fliar Intelligence Index 62/100 | $31M | 4 mo ago | Series A | — | Bobby Reddy Md Co-Founder and COO | TurbopackNode.jsTailwind CSS+13 | 9,865 patents Cell-based immunotherapies, engineered NK/CAR cells, and PET imaging agents for oncology | — |
| 22 | New Equilibrium Biosciences AI-based computational-experimental platform for drug discovery | $20M | 49 mo ago | Series A | 10 | Virginia Burger Founder & CEO | — | — | — |
| 23 | AI Proteins Provider of AI-assisted platform for drug discovery and development | $18M | 34 mo ago | Seed | 19 19 → 41 (+116%) | Chris Bahl Co-Founder | — | 6 patents Patents concentrated in chemistry & materials | — |
| 24 | PHT Corporation Helps pharmaceutical companies and CROs conduct clinical trial programs | $18M | 299 mo ago | Acqui-Hired | 260 | — | — | 2 patents Bias‑free medical UI for visual analog scales and contextual clinical data logging | — |
| 25 | Consensus Provider of an AI-enabled search tool for research purposes | $18M | 22 mo ago | Series B | 6 | Christian Salem Co-Founder | WordPressMySQLPHP+24 | — | 1 launch |
| 26 | Clinical Research IO Provider of a clinical trial management software for researcher | $17M | 25 mo ago | Series B | 16 | — | WordPress Block EditorWordPressApple iCloud Mail+26 | — | 1 partnership |
| 27 | Curavit Contract research organization that offers a complete suite of CRO services for decentralized clinical trials | $16M | 43 mo ago | Series A | 26 | — | WordPressMySQLPHP+29 | — | — |
| 28 | Rhino Health Provider of an AI-based clinical data management solution for hospitals | $16M | 19 mo ago | Seed | 27 | — | — | — | — |
| 29 | Genialis Developer of end-to-end bioinformatics software solutions 53Funding top 33%Growth top 35%Moat top 37%Patents top 38% All 10 signals ▾Fundingtop 33% Growthtop 35% Moattop 37% Patentstop 38% Innovationtop 39% Talenttop 41% Producttop 46% Techtop 50% Globalbottom 44% Marketbottom 35% Funding: Raised $15.3M across 6 rounds · 6 rounds over 11 yrs (0.5/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 53/100 | $15M | 6 mo ago | Series A | 35 | Rafael Rosengarten Chief Executive Officer | WordPressApple iCloud MailGoogle Workspace+23 | 17 patents Patents concentrated in computing, sensing & instrumentation | 1 launch |
| 30 | PhaseV DIgital platform for clinical trial design and closed-loop execution | $15M | 13 mo ago | Series A | 15 | — | Webflowlit-htmllit-element+12 | — | — |
| 31 | Silicon Therapeutics Provider of In-Silico Targeted Engineering platform to build in silico models of human drug targets | $15M | 116 mo ago | Acquired | 61 | Lijun Sun Co-Founder | — | — | — |
| 32 | Phylo Developer of collaborative agents designed for biologists to accelerate discoveries 42Funding top 32%Talent top 38%Tech top 40%Market bottom 37% All 5 signals ▾Fundingtop 32% Talenttop 38% Techtop 40% Marketbottom 37% Globalbottom 33% Funding: Raised $13.5M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 42/100 | $14M | 4 mo ago | Seed | — | Yuanhao Qu Co-Founder & President | SentryNode.jsRadix UI+14 | — | 1 launch · 3 partnerships |
| 33 | Netregulus Quality and regulatory data management solutions for life sciences industry | $13M | 247 mo ago | Acqui-Hired | — | Mark Schaub Founder & CEO | — | — | — |
| 34 | Clara Health Online platform helping patients find suitable clinical trials | $11M | 74 mo ago | Acquired | 36 | — | Node.jsNext.jsstyled-components+19 | — | — |
| 35 | Somite AI-driven platform to produce human tissue for cell-based therapies | $10M | 13 mo ago | Series A | — | Jay Shendure Co-Founder | — | — | — |
| 36 | Mytide Provider of a software solution for peptide therapeutics | $8M | 41 mo ago | Deadpooled | 15 | Jason Norris Co-Founder | — | — | — |
| 37 | ScienceIO Provider of AI solutions transforming medical text into enriched healthcare data | $8M | 56 mo ago | Acquired | 22 | Gaurav Kaushik Founder | ContentfulNode.jsRadix UI+12 | — | — |
| 38 | Plectix Online cell signaling detection tool for drug discovery | $7M | 206 mo ago | Deadpooled | — | Brian Schultz Founder | — | — | — |
| 39 | NeoSoma Provider of an AI-based image analysis and decision-making platform for neurooncologist 40AI top 28%Funding top 40%Patents top 40%Moat top 42% All 8 signals ▾AItop 28% Fundingtop 40% Patentstop 40% Moattop 42% Innovationtop 48% Talentbottom 49% Globalbottom 35% Marketbottom 29% AI: Holds AI/ML patents (G06N-family CPC) · Product described with: ai-based Funding: Raised $6.3M across 5 rounds · 5 rounds over 6 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 40/100 | $6M | 3 mo ago | Series B | 13 | Ken Kolodziej Co-Founder & CEO | — | 7 patents AI-driven MRI segmentation and volumetric analysis of high-grade brain gliomas | — |
| 40 | Basil Systems Provider of AI-powered regulatory, clinical and safety intelligence platform for life sciences | $6M | 13 mo ago | Series A | 11 | Anthony Cirurgiao CEO | — | — | — |
| 41 | YonaLink Cloud-based platform for migrating clinical data saved in health records | $6M | 29 mo ago | Series A | 17 | Gav Martell VP Business Development & Co-Founder | WebflowApple iCloud MailMicrosoft 365+15 | — | — |
| 42 | Genospace Bridging clinical research and care with data-driven precision medicine | $5M | 140 mo ago | Acquired | 22 22 → 42 (+91%) | — | Cart FunctionalitySquarespace CommerceSquarespace+10 | — | — |
| 43 | Frameshift Cloud-based genomic data analytics & visualization platform for researchers | $5M | 33 mo ago | Funding Raised | 12 | Chase Miller Co-Founder & CTO | — | — | — |
| 44 | InCrowd Healthcare professional surveys for life-sciences companies | $3M | 140 mo ago | Acquired | 59 | — | WordPressMySQLPHP+32 | — | — |
| 45 | Meenta Online marketplace for sequencing instruments | $2M | 74 mo ago | Deadpooled | 14 | Stephan Smith Co-Founder & CTO | — | — | — |
| 46 | NE Scientific Real-time ablation simulation software improving cancer treatment outcomes for physicians | $2M | 25 mo ago | Funding Raised | — | Andrea Borsic Founder & CEO | — | 34 patents Patents concentrated in health & consumer products | — |
| 47 | Curoverse Biomedical data solutions empowering precision medicine through open source technology | $2M | 134 mo ago | Acquired | 15 | — | — | — | — |
| 48 | OpenScholar Provider of research asset management platform | $1M | 79 mo ago | Seed | 5 | Gary King Co-Founder | DrupalPHPMathJax+22 | — | 3 launchs |
| 49 | IQ Proteomics Advanced proteomics services for comprehensive proteome characterization, from discovery to targeted analysis | $1M | 117 mo ago | Funding Raised | — | Brian Erickson Co-Founder & CEO | WordPress Block EditorBricksWordPress+13 | 4 patents Isobaric labeling reagents for quantitative proteomics mass‑spectrometry analysis | — |
| 50 | Lattice Automation Software for synthetic biology, design automation, and bio-design workflows | $936K | 110 mo ago | Public | 4 | Douglas Densmore Co-Founder | — | — | — |
Top 12 Life Sciences Tech companies in Boston
#1
Series C · Boston, Massachusetts · founded 2018 · 48 employees$83Mraised▾
Series C · Boston, Massachusetts · founded 2018 · 48 employees
Platform offering CRM software to the medical industry. The platform enables members to personalize customer engagement, identify and quantify opportunities, forecast sales accurately, understand the value of the sales pipeline, empower the sales team, track new launches, understand product adoption and market penetration.
Fliar Intelligence Index™ 53how this company ranks against its industry peers
Funding
top 18%News
top 25%Talent
top 28%Growth
top 35%Product
top 36%Moat
top 39%Funding: Raised $83.0M across 4 rounds · 4 rounds over 5 yrs (0.8/yr) · Last round Series C (Apr 2026)
News: 4 BI events in 12 mo (of 11 tracked, 3 types) · Top themes: Funding, New product
Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Audience (LinkedIn): 15k LinkedIn followers — 3.4% of this cohort's audience
Funding rounds
- Apr 2026Series C$80M
- Jun 2024Series B$45M
- May 2022Series A$31M
- May 2021Series A$7M
Founders & team
Investors
Iconiq Capital, Atreides Management, StepStone Group, Redpoint Ventures, Benchmark, Artisanal Ventures
Tech stack
Apple Icloud MailCloudflareCloudflare Bot ManagementCookieyesCore-JsFacebook Pixel
#2
Series B · Boston, Massachusetts · founded 2014 · 30 employees$99.2Mraised▾
Series B · Boston, Massachusetts · founded 2014 · 30 employees
Provider of a cloud-based data platform for life science industry. It provides a platform that automatically gathers scientific data from lab equipment, gets data ready for analysis and display, and re-engineers raw or primary data into harmonised data.
Fliar Intelligence Index™ 40how this company ranks against its industry peers
Funding
top 21%Growth
top 26%Moat
top 35%Tech
top 50%News
bottom 47%Global
bottom 39%Funding: Raised $99.2M across 6 rounds · 6 rounds over 12 yrs (0.5/yr) · Last round Series B (Feb 2026)
Growth: Headcount 13 → 30 (+131%) across vintages · Web rank 5,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo
Moat: Editorial + unicorn rating 8/10 · IP moat: 4 patents · Soonicorn
Audience (LinkedIn): 57k LinkedIn followers — 13.4% of this cohort's audience
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Senior Product Manager
Funding rounds
- Feb 2026Series B$15M
- Apr 2021Series B$80M
- 2020Series A$11M
- Oct 2019Series A$8M
Investors
Underscore VC, Impetus VC, Alkeon Capital Management, Insight Partners, Y Combinator, Founder Collective
Tech stack
6SenseAmazon SesAmazon Web ServicesApple Icloud MailCloudflareCloudflare Bot Management
#3
Series A · Boston, Massachusetts · founded 2021$30.9Mraised▾
Series A · Boston, Massachusetts · founded 2021
Provider of an AI-native platform for managing clinical trials end-to-end. The platform unifies systems to power faster and higher-quality trials. It operates on a single shared record, eliminating manual reconciliation. Amendments propagate automatically across all workflows, preventing version mismatches. The system provides a unified audit trail across the entire trial process. It integrates AI into operational workflows to improve speed and quality.
Fliar Intelligence Index™ 62how this company ranks against its industry peers
Patents
top 20%Moat
top 21%Growth
top 28%Innovation
top 31%Funding
top 31%Talent
top 38%Patents: 9,865 patents matched (strict assignee match) · 2246 filings since 2022 vs 3287 in 2017-21 · Latest publication 2026
Moat: Editorial + unicorn rating 7/10 · IP moat: 9,865 patents
Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo
Audience (LinkedIn): 4k LinkedIn followers
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: East Coast Clinical Trial Manager
Funding rounds
- Jan 2026Series A$8.6M
Founders & team
Investors
AlleyCorp, Obvious Ventures
Tech stack
Amazon CloudfrontAmazon S3Amazon Web ServicesCore-JsKlaroMicrosoft 365
#4
Series A · Boston, Massachusetts · founded 2015 · 35 employees$15.3Mraised▾
Series A · Boston, Massachusetts · founded 2015 · 35 employees
Developer of end-to-end bioinformatics software solutions. It combines biomedical data management, customizable data analysis pipelines, and interactive visualizations. Its platform is a complete data ecosystem, a solution for sequencing data management, analysis, visualization, and dissemination. It claims that this platform can be easily configured locally or on the cloud and also offers web-based software that automates data management and analysis tasks.
Fliar Intelligence Index™ 53how this company ranks against its industry peers
Funding
top 33%Growth
top 35%Moat
top 37%Patents
top 38%Innovation
top 39%Talent
top 41%Funding: Raised $15.3M across 6 rounds · 6 rounds over 11 yrs (0.5/yr) · Last round Series A (Dec 2025)
Growth: Fresh capital in last 24 mo
Moat: Editorial + unicorn rating 7/10 · IP moat: 17 patents · 10 curated direct competitors tracked
Audience (LinkedIn): 5k LinkedIn followers
Activity (LinkedIn): 1 product launches announced in 12 mo
Funding rounds
- Dec 2025Series A$700K
- Jan 2023Series A$13M
- Oct 2021Grant (prize money)—
- Nov 2017Seed$2.3M
Founders & team
Investors
Redalpine, First Star Ventures, Pikas, Europa, Arrs, Taiwania Capital
Tech stack
Amazon SesAmazon Web ServicesApple Icloud MailBootstrapCloudflareCloudflare Bot Management
#5
Series B · Boston, Massachusetts · founded 2019 · 13 employees$6.3Mraised▾
Series B · Boston, Massachusetts · founded 2019 · 13 employees
Provider of an AI-based image analysis and decision-making platform for neurooncologist. The company has developed an AI-enabled neurooncology platform that assists doctors in clinical management. The company has developed platforms like RANO (Response Assessment Neuro-oncology Criteria) that are made for clinical decision making. It provides 2D image analysis tools for brain tumors. There is an automated version called Neosoma-Glioma Automates RANO. The platform has a medical imaging technology for precise analysis of patients' reports and information. Its products are based and developed on MRI sequences for analysis and modeling.
Fliar Intelligence Index™ 40how this company ranks against its industry peers
AI
top 28%Funding
top 40%Patents
top 40%Moat
top 42%Innovation
top 48%Talent
bottom 49%AI: Holds AI/ML patents (G06N-family CPC) · Product described with: ai-based
Funding: Raised $6.3M across 5 rounds · 5 rounds over 6 yrs (0.8/yr) · Last round Series B (Mar 2026)
Patents: 7 patents matched (strict assignee match) · 7 filings since 2022 vs 0 in 2017-21 · Latest publication 2026
Audience (LinkedIn): 914 LinkedIn followers
Activity (LinkedIn): 1 product launches · 1 partnerships (incl. Inselspital (Insel) and Neosoma GmbH) announced in 12 mo
Funding rounds
- Mar 2026Series B$3.5M
- Dec 2024Series A$345K
- Jul 2024Series A$5.1M
- Aug 2023Seed$1.2M
Founders & team
#6
Seed · Boston, Massachusetts · founded 2020$13.5Mraised▾
Seed · Boston, Massachusetts · founded 2020
Developer of collaborative agents designed for biologists to accelerate discoveries. The agents are designed to help biologists make discoveries faster. It provides a unified workspace where biologists collaborate with agents to get more done. The agents ask clarifying questions, plan alongside the user, and iterate together. It integrates natively with the ecosystem of biomedical research.
Fliar Intelligence Index™ 42how this company ranks against its industry peers
Funding
top 32%Talent
top 38%Tech
top 40%Market
bottom 37%Global
bottom 33%Funding: Raised $13.5M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Seed (Feb 2026)
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Tech: 23 technologies across 5/8 capability areas · Cloud: Amazon Web Services, Cloudflare · Observability: Datadog, Sentry
Audience (LinkedIn): 6k LinkedIn followers
Activity (LinkedIn): 1 product launches · 3 partnerships (incl. Biohub) announced in 12 mo
Funding rounds
- Feb 2026Seed$13.5M
Founders & team
Investors
Andreessen Horowitz, Menlo Ventures, Zetta Venture Partners, Conviction, SV Angel
Tech stack
Amazon Web ServicesCloudflareCloudflare Bot ManagementDatadogGoogle AnalyticsGoogle Font Api
#7
Series B · Boston, Massachusetts · founded 2020 · 22 employees$65Mraised▾
Series B · Boston, Massachusetts · founded 2020 · 22 employees
Developer of programmable medicines to treat multiple diseases. The company uses a state-of-the-art computationally powered Address, Navigate, Design (AND) Platform for identifying optimal localizer that targets the site of disease.
Fliar Intelligence Index™ 42how this company ranks against its industry peers
AI
top 15%Funding
top 24%Talent
top 38%Moat
top 40%Growth
top 43%Patents
bottom 45%AI: Holds AI/ML patents (G06N-family CPC)
Funding: Raised $65.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Series B (Mar 2025)
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Audience (LinkedIn): 6k LinkedIn followers
Activity (LinkedIn): 1 product launches · 1 partnerships (incl. Genethon) announced in 12 mo
Funding rounds
- Mar 2025Series B$65M
Founders & team
Investors
Flagship Pioneering, Lilly
Tech stack
CloudflareCookiebotDocusignGoogle AnalyticsGoogle Font ApiGoogle Hosted Libraries
#8
Series B · Boston, Massachusetts · founded 2016 · 22 employees$91.1Mraised▾
Series B · Boston, Massachusetts · founded 2016 · 22 employees
Developer of re-coding synthetic biology tools. The technology is the integration of computational biology with synthetic biology that involves hacking of the codes to reprogram the organism or biomaterial to reduce its complexity and enhance the efficacy.
Funding rounds
- Jul 2024Series B$60.3M
- Nov 2021Series A$25M
- Sep 2020Grant (prize money)$1M
- Mar 2019Series A$3.7M
Founders & team
Investors
Digitalis Ventures, Innovation Endeavors, America’s Seed Fund, Atlas Venture, Bayer, Redmile Group
Tech stack
WordpressMysqlPhpMaterial Design LiteAnimate.CssWpbakery
#9
Series A · Boston, Massachusetts · founded 2023 · 15 employees$15Mraised▾
Series A · Boston, Massachusetts · founded 2023 · 15 employees
DIgital platform for clinical trial design and closed-loop execution. The company leverages cutting-edge algorithms such as reinforcement learning and causal ML for adaptive trial design and closed-loop. It also enable the detection of hidden signals in data while analyzing clinical trial results and extracting actionable insights.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 7k LinkedIn followers
Funding rounds
- May 2025Series A$50M
- Oct 2023Seed$15M
Investors
Viola Ventures, LionBird, Exor, Accel, Insight Partners, Viola Group
Tech stack
CloudflareCookieyesGoogle AnalyticsGoogle WorkspaceHstsHttp/3
#10
Series A · Boston, Massachusetts · founded 2023$10.1Mraised▾
Series A · Boston, Massachusetts · founded 2023
AI-driven platform to produce human tissue for cell-based therapies. The company develops a digital twin of the embryo, a computational model simulating real embryo development to guide decision-making for generating cell-based therapies.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers
Funding rounds
- May 2025Series A$47M
- Sep 2024Seed$4.8M
- Apr 2024Seed$5.3M
Founders & team
Investors
TechAviv, Next Coast Ventures, Trust Ventures, Texas Ventures Partners, Astellas Venture Management, Montage Ventures
#11
Series C · Boston, Massachusetts · founded 2000 · 172 employees$334Mraised▾
Series C · Boston, Massachusetts · founded 2000 · 172 employees
SmartLabs are coworking lab spaces offering research products and desks. The company offer packages such as an innovative suite (3-7 persons) for research projects, a scaling lab suite (8-100+ person research teams) for large pharma or academic research teams, and a vivarium for large pharma companies.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 12k LinkedIn followers — 2.8% of this cohort's audience
Activity: 1 product launches · 1 partnerships · 2 expansions (incl. SmartLabs) announced in 12 mo
Funding rounds
- Jan 2024Series C$48M
- Sep 2021Series B$250M
- Mar 2020Series A$36M
Founders & team
Investors
ArrowMark Partners, Breed's Hill Capital, Conversion Venture Capital, Ropes & Gray, Winslow Capital, Onex Falcon
Tech stack
AdrollAdroll Cmp SystemApple Icloud MailBeaver BuilderBugherdCdnjs
#12
Series B · Boston, Massachusetts · founded 2017$31.1Mraised▾
Series B · Boston, Massachusetts · founded 2017
Provider of medical data labeling solutions for AI development. This company offers human-powered and AI-assisted labeling services for various data types, including text, images, audio, and video. It utilizes a global network of medical professionals to ensure accuracy and scalability. The platform provides tools for quality control and performance measurement, allowing clients to manage annotation quality effectively. Seamless API integration enables embedding data annotation into existing data pipelines. The company also offers insights into dataset nuances to improve model development.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 7k LinkedIn followers
Hiring: 2 hiring posts in 12 mo (public) · momentum +2 · hiring: Laber Operations Lead, Senior Analyst of Sourcing Operations
Funding rounds
- Oct 2024Series B$16M
- Sep 2021Series A$15M
- Mar 2019Seed$150K
Founders & team
Investors
SignalFire, Alumni Ventures, Samsung NEXT, Matrix, Susa Ventures, Y Combinator
Tech stack
6SenseAmazon Web ServicesCdnjsCloudflareCloudflare Bot ManagementCore-Js
Funding & investor landscape
$4Btotal disclosed funding
55companies funded
151disclosed rounds
1rounds last 90 days
Most active investors
Insight Partners3 rounds
Techstars3 rounds
Notable founders
Michael Monovoukas
Co-Founder & CEO · AcuityMD
Robert Coe
Co-Founder & CTO · AcuityMD
Bobby Reddy Md
Co-Founder and COO · Pi Health
Geoffrey Kim
Chief Executive Officer; Co-Founder · Pi Health
Rafael Rosengarten
Chief Executive Officer · Genialis
Ken Kolodziej
Co-Founder & CEO · NeoSoma
Yuanhao Qu
Co-Founder & President · Phylo
Kexin Huang
Co-Founder & CEO · Phylo
Raffi Afeyan
Co-Founder & Chief Innovation Officer · Ampersand
Jason Gardner
CEO · Ampersand
Daniel Mandell
CEO · GRO Biosciences
Jay Shendure
Co-Founder · Somite
Prism market signals · United States · country-scoped Prism corpus, 2,593,976 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH IN BOSTON · Health & Bio
How research on Biotechnology in Boston is moving
A read on the academic research around Biotechnology in Boston — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 88 papers.
Boston Children's Hospital and Boston University lead RNA modification, splicing, and CRISPR research (59 recent vs. 29 early papers), with an optimistic stance (mean 0.53) despite minor concern.
88 papers · stance +0.53 · 44% breakthrough · 13% concern
top institutions
- Boston Children\'s Hospital35
- Boston University24
- Boston Children\'s Museum9
- University of Massachusetts Boston7
- Boston VA Research Institute5
leading researchers
Adam Sychla · Bruce Cosgrove · Cary N. Weiss · Peng Lyu · Silvi Rouskin · Vijay G. Sankaran
prism intelligence · tone & topics
92% positive · 0% critical tone
Medical ResearchPharmaceuticalsHealthGeneticsHealthcareBiology
▲
Breakthroughs34 · 39%
▼ 43%→37% share
▼0.9× share momentum0 median citations65% since 2021mostly empirical
Cell biology research is rising sharply — 5 new papers, with 'Cell' emerging as a brand-new sub-topic adding 3 more.
rising sub-themes (early→recent)
- Cell biology5
- In vivo5
- Gene4
- RNA-binding protein3
- Messenger RNA3
Newly emergingCell 0→3
Landmark Reconstituting Organ-Level Lung Functions on a Chip · 4,038 cites
◆
Advancements33 · 38%
▲ 35%→37% share
▲1.1× share momentum0 median citations67% since 2021mostly empirical
Advancements are intensifying — field-share grew 35%→37%, led by Haematopoiesis and Somatic cell each gaining 3 papers.
rising sub-themes (early→recent)
- Haematopoiesis3
- Somatic cell3
- Epigenetics2
- Disease2
- Healthy aging2
Landmark Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice · 1,441 cites
▼
Concerns10 · 11%
▼ 17%→10% share
▼0.6× share momentum1 median citations60% since 2021mostly empirical
Concerns are cooling overall — field-share dropped 17%→10%, despite Antimicrobial stewardship and Psychological intervention each rising by 2 papers.
rising sub-themes (early→recent)
- Antimicrobial stewardship2
- Psychological intervention2
- In vivo2
- Directionality1
- Cloning (programming)1
Landmark Biphasic Dose Response in Low Level Light Therapy · 1,105 cites
Common questions
How many Life Sciences Tech companies are there in Boston, United States?
Radar tracks 107 indexable Life Sciences Tech companies headquartered in Boston, United States that meet our profile-completeness bar.
What is the total funding raised by Life Sciences Tech companies in Boston, United States?
The Life Sciences Tech companies in Boston, United States on this list have raised a combined $4B in disclosed equity funding across 55 funded companies.
Which is the highest-funded Life Sciences Tech company in Boston, United States?
Genuity Science is the highest-funded Life Sciences Tech company in Boston, United States, with $515M in disclosed equity funding.
How many Life Sciences Tech companies in Boston, United States are funded?
55 of the 107 Life Sciences Tech companies in Boston, United States on this list have disclosed at least one equity funding round.
How many Life Sciences Tech unicorns are there in Boston, United States?
2 Life Sciences Tech companies in Boston, United States on this list are valued at $1B or more.
Who are the top investors in Boston, United States Life Sciences Tech companies?
The most active investors in Boston, United States Life Sciences Tech companies on this list include HHS, MIT Startup Exchange, Dorm Room Fund, Rough Draft Ventures, Alumni Ventures.
Rohit KhannaTrends & Stories
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.